PNC Financial Services Group
CODX

PNC Financial Services Group’s Co-Diagnostics CODX Stock Holding History

PNC Financial Services Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-133
Closed -$5.32K – 4712
2023
Q4 		$5.32K Hold
133
– – ﹤0.01% 3928
2023
Q3 		$4.24K Hold
133
– – ﹤0.01% 4031
2023
Q2 		$4.44K Hold
133
– – ﹤0.01% 4144
2023
Q1 		$5.92K Hold
133
– – ﹤0.01% 3981
2022
Q4 		$10.1K Buy
+133
New +$12.5K ﹤0.01% 3776
2020
Q3 		– Sell
-7
Closed -$4K – 3937
2020
Q2 		$4K Buy
+7
New +$3.19K ﹤0.01% 3669

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group's CODX Position: Q1 2024 in Review

PNC Financial Services Group sold out of Co-Diagnostics (CODX) in Q1 2024, closing a stake of 133 shares — an estimated $5.32K sold.

PNC Financial Services Group first reported a position in CODX in Q2 2020 and held it in 6 quarters. The position peaked at $10.1K in Q4 2022. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2024.

  • PNC Financial Services Group reported no remaining Co-Diagnostics position as of Q1 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 133 Co-Diagnostics shares in Q1 2024, an estimated $5.32K.
  • PNC Financial Services Group first reported a position in Co-Diagnostics in Q2 2020 and held it in 6 quarters.
  • PNC Financial Services Group's Co-Diagnostics position peaked at $10.1K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.